-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NotXGaxZr5ljqSI3HojnzzJjd0FRYvXeSA5kU4WzHJwEomK+cdk0c+Yscv4rziv6 01Y5jLNKYdqpk0yrvZAaAw== 0000950133-05-001542.txt : 20050412 0000950133-05-001542.hdr.sgml : 20050412 20050412163537 ACCESSION NUMBER: 0000950133-05-001542 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050412 DATE AS OF CHANGE: 20050412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-108133 FILM NUMBER: 05746522 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY ST CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 424B3 1 w07758e424b3.htm 424B3 e424b3
 

Rule 424(b)(3)
Registration No. 333-108133

PROSPECTUS SUPPLEMENT NO. 7 TO PROSPECTUS DATED NOVEMBER 12, 2003

GUILFORD PHARMACEUTICALS INC.

$69,354,000

5% Convertible Subordinated Notes
Due July 1, 2008

and

11,114,423 Shares of Common Stock
Issuable Upon Conversion of the Notes

The date of this prospectus supplement is April 12, 2005

     This prospectus supplement identifies below holders of notes, or transferees, donees, pledgees and successors thereof, who may, from time to time, offer and sell pursuant to this prospectus supplement any or all of the notes listed below and common stock into which those notes are convertible.

     You should read this prospectus supplement together with the prospectus dated November 12, 2003, which is to be delivered with this prospectus supplement.

     Investing in our common stock or the notes involves a high degree of risk. Please carefully consider the “Risk Factors — Risks Related to this Offering” beginning on page 18 of the prospectus.

     Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy of this prospectus. Any representation to the contrary is a criminal offense.

     The table below sets forth additional and updated information concerning beneficial ownership of the notes, and replaces the table appearing under the caption “Selling Holders” beginning on page 22 of the prospectus. We have prepared this table based on information given to us by the selling holders.

                 
    Principal Amount of   Shares of Common        
    Notes Beneficially   Stock Owned Prior   Shares of Common   Shares of Common
    Owned and   to the   Stock   Stock Owned After
Name of Beneficial Owner   Offered(1)   Offering(1)(2)(3)   Offered(1)(3)   Completion of the Offering
AIG DKR SoundShore Holdings Ltd.
   $2,000,000   320,512   320,512   0
AIG DKR SoundShore Private Investors Holding Fund Ltd.
   $2,000,000   320,512   320,512   0
AIG DKR SoundShore Strategic Holding Fund Ltd.
   $2,000,000   320,512   320,512   0
Alexandra Global Master Fund LTD.
   $5,500,000   881,410   881,410   0
Argent Classic Convertible Arbitrage (Bermuda) Fund Ltd.
   $1,383,000   221,634   221,634   0
Argent Classic Convertible Arbitrage Fund, LP
   $700,000   112,179   112,179   0
Bancroft Convertible Fund, Inc.
   $500,000   80,128   80,128   0
Barclays Global Investors Equity Hedge Fund II
   $11,000   1,762   1,762   0
BP Amoco PLC Master Trust
   $103,000   16,506   16,506   0
CIBC World Markets
   $500,000   80,128   80,128   0

 

 

                 
    Principal Amount of   Shares of Common        
    Notes Beneficially   Stock Owned Prior   Shares of Common   Shares of Common
    Owned and   to the   Stock   Stock Owned After
Name of Beneficial Owner   Offered(1)   Offering(1)(2)(3)   Offered(1)(3)   Completion of the Offering
Citigroup Global Markets Inc.
   $2,220,000   355,769   355,769   0
Ellsworth Convertible Growth and Income Fund, Inc.
   $500,000   80,128   80,128   0
HFR TQA Master Trust
   $175,000   28,044   28,044   0
Hotel Union & Hotel Industry of Hawaii Pension Plan
   $40,000   6,410   6,410   0
LDG Limited
   $107,000   17,147   17,147   0
Leslie Steppel Weisbrod, IRA
   $50,000   26,712   8,012   18,700
Lexington Vantage Fund
   $17,000   2,724   2,724   0
Merlin Biomed Investment Advisors Employees’ 401K Plan
   $100,000   53,525   16,025   37,500
Merlin Biomed Longterm Appreciation LP
   $545,000   318,539   87,339   231,200
Merlin Biomed Offshore Master Fund
   $1,205,000   704,508   193,108   511,400
RAM Trading Inc.
   $2,000,000   320,512   320,512   0
Ritchie Capital Management, LLC
   $1,000,000   160,256   160,256   0
Ritchie Convertible Arbitrage Trading
   $1,000,000   160,256   160,256   0
Scorpion Offshore Investment Fund, Ltd.
   $68,000   10,897   10,897   0
Singlehedge U.S. Convertible Arbitrage Fund
   $131,000   20,993   20,993   0
SP Holdings Ltd.
   $37,000   5,929   5,929   0
Sphinx Convertible Arb Fund SPC
   $37,000   5,929   5,929   0
Sphinx Fund
   $24,000   3,846   3,846   0
SSI Blended Market Neutral L.P.
   $64,000   10,256   10,256   0
Standard Global Equity Partners, L.P.
   $292,000   46,794   46,794   0
Standard Global Equity Partners II, L.P.
   $12,000   1,923   1,923   0
Standard Global Equity Partners SA, L.P.
   $111,000   17,788   17,788   0
Standard Pacific Capital Offshore Fund, Ltd.
   $946,000   151,602   151,602   0
Standard Pacific MAC 16 Ltd.
   $48,000   7,692   7,692   0
Stuart Weisbrod, IRA
   $100,000   53,525   16,025   37,500
Sunrise Partners Limited Partnership
   $150,000   24,038   24,038   0
TQA Master Fund Ltd.
   $1,247,000   199,839   199,839   0
TQA Master Plus Fund, Ltd.
   $782,000   125,320   125,320   0
UBS AG London Branch
   $12,000,000   1,923,076   1,923,076   0
Viacom Inc. Pension Plan Master Trust
   $4,000   641   641   0
Whitebox Convertible Arbitrage Partners, LP
   $2,000,000   320,512   320,512   0
Xavex — Convertible Arbitrage 7 Fund
   $174,000   27,884   27,884   0
Zurich Institutional Benchmarks Master Fund Ltd. c/o TQA Investors LLC
   $125,000   20,032   20,032   0
Zurich Institutional Benchmarks Master Fund Ltd., c/o SSI Investment Management, Inc.
   $252,000   40,384   40,384   0

    (1) The principal amount of notes and common stock identified in this table and in the Selling Holder table in the prospectus dated November 12, 2003, as beneficially owned and offered may exceed the total amount of notes and common stock identified on the cover page of the prospectus. However, in no event will the Selling Holders, in the aggregate, sell pursuant to the prospectus, as supplemented from time-to-time, more than $69,354,000 aggregate principal amount of notes or the 11,114,423 shares issuable upon conversion of the notes.
 
    (2) Includes common stock into which the notes are convertible.
 
    (3) Assumes a conversion rate of 160.2564 shares per $1,000 principal amount of notes and a cash payment in lieu of any fractional interest.

2

-----END PRIVACY-ENHANCED MESSAGE-----